Clin2
NCT07039019Possibly a fitRecruiting

Prednisone for Non-Specific Pleuritis

Pleuritis, Non-specific

Part of Infections, Lungs & breathing clinical trials.

This trial tests if a short course of the steroid prednisone can help people with nonspecific pleuritis—inflammation of the lung lining without a known cause. If you haven't responded to other treatments, this study aims to see if prednisone is a safe and effective option.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
40 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must have been diagnosed with non-specific pleuritis (inflammation of the lining around your lungs that doesn't have a clear cause). The diagnosis must be confirmed by a biopsy (a small sample taken from the lining).
  • Blood tests for autoimmune diseases (like lupus, rheumatoid arthritis, and others) must be negative.
  • You cannot have chronic or fibrinous pleuritis (a long-term, scar-like form of the condition).
  • You cannot have empyema (a pocket of pus in the chest caused by infection).
  • You cannot be taking steroids or other immune-suppressing medicines for any other reason right now.
  • You must be able to understand the study and give your own consent.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04376216Recruiting· Phase 4
Prednisolone for biopsy-proven acute interstitial kidney inflammation

This trial tests whether prednisolone (a steroid medicine) helps people with acute interstitial nephritis, a sudden inflammation of the kidney tissue. You may qualify if your diagnosis was confirmed by kidney biopsy and your kidney function has worsened recently.

Herning
NCT06731647Recruiting· Phase 2
Anti-inflammatory drugs for pleurodesis in pneumothorax

This trial tests whether using non-steroidal anti-inflammatory drugs (NSAIDs) during pleurodesis (a procedure to seal the lung lining) helps people with a collapsed lung (pneumothorax). It aims to see if these drugs can improve outcomes.

Amiens
NCT06472219Recruiting· Phase 3
PREDICATE trial for serious lung infections

This trial tests a new approach to treating serious respiratory infections in hospitalized adults. It aims to see if a targeted strategy works better than standard care while avoiding extra risks.

Hong Kong
NCT07210008Not yet recruiting· Phase 3
Testing steroids for scarred lung caused by allergy

This trial tests whether corticosteroid therapy can help people with a type of lung scarring caused by an allergic reaction (hypersensitivity pneumonitis). It compares the steroid to a placebo to see if it improves breathing and lung function.

NCT06251232Not yet recruiting· Phase 2
Prednisone for drug-induced liver injury

This trial tests whether the steroid prednisone can safely and effectively help people whose liver has been damaged by a medication and hasn't started to improve after stopping that drug. If you have moderate to severe liver injury from a medicine and your liver enzymes are still high, this might be an option.

NCT07151456Not yet recruiting· Phase 4
Short-term steroids for steroid-sensitive nephrotic syndrome

This trial tests whether a shorter course of steroids works well for adults with steroid-sensitive nephrotic syndrome. If you have this condition and your protein levels are very high, this study may help find a treatment that is just as effective but with fewer side effects.

Wenzhou, Zhejiang

Hear when a new Pleuritis, Non-specific trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.